Sun, Sep 14, 2014, 11:29 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

  • citiccgirl citiccgirl Oct 22, 2010 10:04 AM Flag

    GHDX read the news...

    11-Oct-10 08:07 ET GHDX Genomic Health announces analysis from First European clinical decision making study of Oncotype DX breast cancer test among Spanish physicians (14.06 ) Co announces positive results from a prospective, multi-center, study that showed the Oncotype DX Recurrence Score result had a significant impact on treatment decisions for early-stage breast cancer patients in Spain. The study found that knowledge of a patient's RS changed oncologists' treatment recommendations in 31.8 percent of cases, which is similar to what has been shown in U.S. studies evaluating the impact of the RS on treatment decisions.

    October 5, 2010
    06:11 EDT GHDX Genomic Health announces agreement with IDBS
    IDBS announced that Genomic Health has selected IDBS to provide the tools for its new clinical research data management and decision capture platform.

    •Genomic Health (GHDX 14.90) Director/10% owner Baker Brothers bought 65,466 shares at $14.37-14.54

    SortNewest  |  Oldest  |  Most Replied Expand all replies
28.99-0.96(-3.21%)Sep 12 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
21Vianet Group, Inc.
NasdaqGSFri, Sep 12, 2014 4:00 PM EDT
Darden Restaurants, Inc.
NYSEFri, Sep 12, 2014 4:03 PM EDT